SCHEMBL6779494

SCHEMBL6779494

O=C(NCc1ccccc1-c1ccccc1)c1ccncc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.65
▸ MMP13 P45452 2/20 0.61
▸ ROCK2 O75116 3/20 0.59
▸ ROCK1 Q13464 2/20 0.57
▸ RPS6KA5 O75582 1/20 0.57
▸ MAP4K4 O95819 1/20 0.57
▸ PRKCG P05129 1/20 0.57
▸ PRKACA P17612 1/20 0.57
▸ RPS6KB1 P23443 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ AKT1 P31749 1/20 0.57
▸ GSK3A P49840 1/20 0.57
▸ GSK3B P49841 1/20 0.57
▸ PRKX P51817 1/20 0.57
▸ PRKCD Q05655 1/20 0.57
▸ PRKG2 Q13237 1/20 0.57
▸ DYRK1A Q13627 1/20 0.57
▸ PRKG1 Q13976 1/20 0.57
▸ PKN2 Q16513 1/20 0.57
▸ CDC42BPA Q5VT25 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209853 0.82 ROCK2 (0.52) KMT2AMMP13ROCK2SMN1; SMN2RAB9A
SCHEMBL27833527 0.80 KMT2A (0.70) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL30780061 0.79 HPGD (0.77) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL1568246 0.79 SMN1; SMN2 (0.68) KMT2AROCK2MAPK1SMN1; SMN2RAB9A
SCHEMBL1568699 0.79 NAMPT (0.69) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL1568387 0.79 HPGD (0.77) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL4658947 0.79 KMT2A (0.68) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL27833534 0.78 KMT2A (0.63) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL1569194 0.78 ROCK2 (0.82) KMT2AMMP13ROCK2ROCK1RPS6KA5
SCHEMBL5883325 0.77 KMT2A (0.55) KMT2ASMN1; SMN2RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
Send feedback